Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Egevad L, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Kench JG.
Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.
PMID:30477882
The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guerin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.
Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T.
J Urol. 2015 Jan;193(1):58-63. doi: 10.1016/j.juro.2014.07.114. Epub 2014 Aug 12.
PMID:25106902
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P, Wang ZC, Yu X, Lin J, He Q.
BMC Urol. 2015 May 30;15:46. doi: 10.1186/s12894-015-0037-2.
PMID:26025446
Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.